BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26717857)

  • 1. Apathy and striatal dopamine defects in non-demented patients with Parkinson's disease.
    Chung SJ; Lee JJ; Ham JH; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2016 Feb; 23():62-5. PubMed ID: 26717857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients.
    Santangelo G; Vitale C; Picillo M; Cuoco S; Moccia M; Pezzella D; Erro R; Longo K; Vicidomini C; Pellecchia MT; Amboni M; Brunetti A; Salvatore M; Barone P; Pappatà S
    Parkinsonism Relat Disord; 2015 May; 21(5):489-93. PubMed ID: 25753457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apathy Reflects Extra-Striatal Dopaminergic Degeneration in de novo Parkinson's Disease.
    Sampedro F; Martínez-Horta S; Marín-Lahoz J; Pagonabarraga J; Kulisevsky J
    J Parkinsons Dis; 2022; 12(5):1567-1574. PubMed ID: 35491803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid eye movement sleep behaviour disorder and striatal dopamine depletion in patients with Parkinson's disease.
    Chung SJ; Lee Y; Lee JJ; Lee PH; Sohn YH
    Eur J Neurol; 2017 Oct; 24(10):1314-1319. PubMed ID: 28782870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease.
    Koerts J; Leenders KL; Koning M; Portman AT; van Beilen M
    Eur J Neurosci; 2007 May; 25(10):3132-6. PubMed ID: 17561826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal Dopamine Depletion Patterns and Early Non-Motor Burden in Parkinsons Disease.
    Chung SJ; Lee JJ; Ham JH; Ye BS; Lee PH; Sohn YH
    PLoS One; 2016; 11(8):e0161316. PubMed ID: 27529171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Correlations Between Dopaminergic Function and Motivation in Parkinson's Disease.
    Hinkle JT; Mills KA; Perepezko K; Pontone GM
    J Geriatr Psychiatry Neurol; 2022 May; 35(3):353-362. PubMed ID: 33622073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy.
    Baggio HC; Segura B; Garrido-Millan JL; Marti MJ; Compta Y; Valldeoriola F; Tolosa E; Junque C
    Mov Disord; 2015 Apr; 30(5):671-9. PubMed ID: 25600482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson's disease.
    Jaakkola E; Joutsa J; Mäkinen E; Johansson J; Kaasinen V
    Eur J Neurol; 2017 Nov; 24(11):1341-1347. PubMed ID: 28834102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the Non-Motor Burden with Patterns of Striatal Dopamine Loss in de novo Parkinson's Disease.
    Chung SJ; Lee S; Yoo HS; Lee YH; Lee HS; Choi Y; Lee PH; Yun M; Sohn YH
    J Parkinsons Dis; 2020; 10(4):1541-1549. PubMed ID: 32925098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered striatal circuits underlie characteristic personality traits in Parkinson's disease.
    Ishii T; Sawamoto N; Tabu H; Kawashima H; Okada T; Togashi K; Takahashi R; Fukuyama H
    J Neurol; 2016 Sep; 263(9):1828-39. PubMed ID: 27334907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of β-Amyloid with Cognition and Striatal Dopamine in Early, Non-Demented Parkinson's Disease.
    Oh YS; Yoo SW; Lyoo CH; Yoo JY; Yoon H; Ha S; Lee KS; Kim JS
    J Parkinsons Dis; 2021; 11(2):605-613. PubMed ID: 33646180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of striatal dopamine depletion in early Parkinson disease: Prognostic relevance.
    Chung SJ; Lee HS; Yoo HS; Lee YH; Lee PH; Sohn YH
    Neurology; 2020 Jul; 95(3):e280-e290. PubMed ID: 32616674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.